Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-20-046581

Director sold 2,860 shares at $11.90 ($34,038)

  • Director acquired 7,956 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Crane Rosemary A · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-08-11 Exercise or conversion : show line 1 in the form +7,956 36,369 D
2020-08-11 Sale : show line 2 in the form −2,860 $11.90 $34,038 33,509 D
Open-market sales · 2,860 sh · avg $11.90 · $34,038

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-08-11 Exercise or conversion : show line 3 in the form Restricted Share Units −7,956 0 D
Loading xslF345X03/doc4.xml…